# Trade Mark Journal No.2025/035 29 August 2025

## WO0000001870285 (9,42)

Office of origin: United States of America

Date of International Registration:9 June 2025
Date of designation in the UK: 9 June 2025

The mark consists of the word "HELIANTHOS" with the design of a flower with petals, above the letter "H".

International priority date claimed: 12 December 2024 (United States of America) (98899942)

Class 9
  Bioreactor system comprised of a bioreactor for cell culturing, sensors, filters, and tubing attached to a rigid panel for perfusion fermentation; bioreactor system comprised of a bioreactor for cell culturing, sensors, filters, and tubing attached to a rigid panel to continuously process and test parameters and collect data on a range of variables; bioreactor system comprised of a bioreactor for cell culturing, sensors, filters, and tubing attached to a rigid panel for continuous protein, molecule, or cell line production using microbes; scientific apparatus for the biomanufacturing, expression, purification and collection of proteins and drug substances.
Class 42
  Product development; product development in the fields of protein manufacturing; research and development of technology in the field of protein manufacturing; platform as a service services (PaaS) featuring software for designing and developing new products using protein manufacturing; product research and development in the biotechnology field.

Sunflower Therapeutics, PBC

Representative: Rachelle A. Dubow, Esq. Morgan, Lewis & Bockius LLP, One Federal Street, Boston MA 02110, UNITED STATES OF AMERICA